Department of Medicine

From the tiniest ticks of genetic expression to the sweep of organ systems, medical students gain a deep understanding of human body function. They spend hundreds of hours learning how to use tools and technologies, from stethoscopes to point of care ultrasound, to deliver the best patient care they can. However, when it comes to thorny societal issues like the intersection of race and class in medicine, unequal access to health care, and the outsized toll chronic disease can take on marginalized populations, medical students have historically had little opportunity to engage.

With new funding from the Substance Abuse and Mental Health Services Administration, UVM Associate Professor of Medicine Halle Sobel, M.D., and Elly Riser, M.D., UVM clinical instructor in medicine, are working to bring training on treating opioid use disorder as a chronic condition to physicians at the beginning of their careers – during medical school.

University of Vermont scientists, physicians, and students gathered at the Larner College of Medicine February 6 for the first-ever on-campus “virus slam” hosted by the Translational Global Infectious Diseases Research Center. At the event, some twenty experts, from five UVM colleges and institutes, gave five-minute mini-talks that ranged from explaining the biochemistry of the virus’ interaction with the human immune system to interpreting the latest data from the World Health Organization.

Mary Cushman, M.D., M.Sc., UVM professor of medicine and director of the Thrombosis and Hemostasis Program at the UVM Medical Center, commented on an Arteriosclerosis, Thrombosis, and Vascular Biology study on the potential increased risk of blood clots in people with blood types A and B in U.S. News & World Report.

Glenn Goldman, M.D., professor of medicine and chief of dermatology, was invested as the inaugural Rogers and Nancy Follansbee Professor of Dermatology during a formal ceremony held February 3, 2020 at the Larner College of Medicine at the University of Vermont.